MICS: the European picture

Article

Feature includes: statistics providing a true picture of the number of European surgeons practising MICS; interviews with European experts; why you should adopt the technique; product showcase.

Key Points

So has industry satisfied today's cataract surgeon or does research and development still have some way to go? Naturally, there will always be room for improvement and research will continue to deliver innovative products; however, many do believe that surgeons now have the instruments necessary to allow them to offer patients a truly first-class MICS service. But are the surgeons convinced?

Belgian market intelligence firm, Tools for Growth, set about finding the answer. They assessed European surgeons' attitudes towards MICS, in the hope of finding out how the introduction of these new technologies has influenced the way they actually perform cataract surgery today.

By conducting, what we believe to be, the most comprehensive and insightful independent market research survey ever performed,1 we can now present the true picture of European cataract surgery today.

The market intelligence firm questioned 915 surgeons in France (n=180), Germany (n=200), the UK (n=175), Italy (n=180) and Spain (n=180) at 720 sites across Europe, including public hospitals, private hospitals, eye clinics and private practices between January and February 2008. The distribution of surgeons questioned accurately mirrored the current climate, with approximately one-third of surgeons operating within a public hospital.

Not only were surgeons questioned about their current practice styles, but they were also asked to predict what style of surgery they believe they would be performing in two years' time.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.